COVID-19 Convalescent Plasma Assays and Outcomes: Global Perspectives

Program Description: 

This cutting-edge program will feature a discussion about the latest research on treatment with COVID-19 convalescent plasma (CCP). Speakers will also address how to compare and correlate different assays to high and low titers under the EUA in the US. In addition to hearing from the PI of the recent INFANT study from Argentina, attendees will also learn about other approaches to neutralizing antibody assays and their importance in research and study design. Lastly, speakers will close the discussion with an extended question-and-answer period.

The event’s speakers include Dana Devine, PhD; Larry J. Dumont, MBA, PhD; and Fernando Polack, MD. The discussion will be moderated by Claudia S. Cohn, MD, PhD, Chief Medical Officer, AABB.

As an added value of AABB membership, this program is complimentary to AABB individual members through the generous support of Creative Testing Solutions and Digi-Trax (the cost for nonmembers is $69). Registration is required and includes access to both the live and on-demand version of this program.

To register for this event, please click here.